A Randomized, Double-Masked, Pilot Study of the Safety and Efficacy of 0.5 ug/day and .02 ug/day IIuvien (Fluocinolone Acetonide Intravitreal Insert) 0.19mg in Subjects with Macular Edema Secondary to Retinal Vein Occlusion

Grants and Contracts Details

StatusFinished
Effective start/end date9/4/09 → 8/31/14

Funding

  • Alimera Sciences Incorporated: $34,358.00